Stryker Stock Forecast, Price & News

20 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Stryker in the last twelve months. There are currently 1 sell rating, 6 hold ratings and 13 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Stryker stock.
View analyst ratings for Stryker or view top-rated stocks.

Wall Street analysts have given Stryker a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Stryker wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Stryker saw a increase in short interest during the month of May. As of May 28th, there was short interest totaling 3,870,000 shares, an increase of 28.1% from the May 13th total of 3,020,000 shares. Based on an average trading volume of 1,120,000 shares, the days-to-cover ratio is presently 3.5 days. Approximately 1.1% of the company's stock are short sold.
View Stryker's Short Interest.

Stryker is scheduled to release its next quarterly earnings announcement on Thursday, July 29th 2021.
View our earnings forecast for Stryker.

Stryker Co. (NYSE:SYK) issued its quarterly earnings results on Monday, April, 26th. The medical technology company reported $1.93 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.99 by $0.06. The medical technology company earned $3.95 billion during the quarter, compared to analyst estimates of $3.94 billion. Stryker had a trailing twelve-month return on equity of 21.90% and a net margin of 9.57%. Stryker's quarterly revenue was up 10.2% compared to the same quarter last year. During the same quarter in the prior year, the company posted $1.84 earnings per share.
View Stryker's earnings history.

Stryker's stock was trading at $175.62 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, SYK stock has increased by 49.6% and is now trading at $262.64.
View which stocks have been most impacted by COVID-19.

Stryker declared a quarterly dividend on Tuesday, May 4th. Shareholders of record on Wednesday, June 30th will be paid a dividend of $0.63 per share on Friday, July 30th. This represents a $2.52 dividend on an annualized basis and a yield of 0.96%. The ex-dividend date of this dividend is Tuesday, June 29th.
View Stryker's dividend history.

Stryker pays an annual dividend of $2.52 per share and currently has a dividend yield of 0.96%. Stryker does not yet have a strong track record of dividend growth. The dividend payout ratio of Stryker is 33.92%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Stryker will have a dividend payout ratio of 24.23% next year. This indicates that Stryker will be able to sustain or increase its dividend.
View Stryker's dividend history.

Stryker issued an update on its FY 2021 earnings guidance on Tuesday, May, 4th. The company provided EPS guidance of 9.050-9.300 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $9.080. The company issued revenue guidance of -.

20 brokers have issued 1 year target prices for Stryker's shares. Their forecasts range from $215.00 to $303.00. On average, they anticipate Stryker's share price to reach $268.18 in the next year. This suggests a possible upside of 2.1% from the stock's current price.
View analysts' price targets for Stryker or view top-rated stocks among Wall Street analysts.

1,492 employees have rated Stryker CEO Kevin A. Lobo on Glassdoor.com. Kevin A. Lobo has an approval rating of 97% among Stryker's employees. This puts Kevin A. Lobo in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

Some companies that are related to Stryker include Abbott Laboratories (ABT), Medtronic (MDT), Intuitive Surgical (ISRG), Becton, Dickinson and (BDX), Edwards Lifesciences (EW), Boston Scientific (BSX), IDEXX Laboratories (IDXX), DexCom (DXCM), Baxter International (BAX), ResMed (RMD), Teleflex (TFX), Insulet (PODD), STERIS (STE), Hologic (HOLX) and Abiomed (ABMD).
View all of SYK's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Stryker investors own include Johnson & Johnson (JNJ), The Walt Disney (DIS), The Home Depot (HD), Medtronic (MDT), Visa (V), AbbVie (ABBV), Cisco Systems (CSCO), Intel (INTC), QUALCOMM (QCOM) and NVIDIA (NVDA).

Stryker trades on the New York Stock Exchange (NYSE) under the ticker symbol "SYK."

Stryker's stock is owned by a variety of retail and institutional investors. Top institutional investors include Price T Rowe Associates Inc. MD (7.38%), BlackRock Inc. (6.53%), Greenleaf Trust (5.41%), Bank of New York Mellon Corp (1.96%), Franklin Resources Inc. (1.50%) and Massachusetts Financial Services Co. MA (1.35%). Company insiders that own Stryker stock include Allan C Golston, Glenn S Boehnlein, Katherine Ann Owen, Kevin Lobo, M Kathryn Fink, Roch Doliveux, Srikant M Datar and Timothy J Scannell.
View institutional ownership trends for Stryker.

SYK stock was sold by a variety of institutional investors in the last quarter, including Price T Rowe Associates Inc. MD, BlackRock Inc., BlueSpruce Investments LP, Greenleaf Trust, Massachusetts Financial Services Co. MA, State of Michigan Retirement System, Bank of Nova Scotia, and Healthcare of Ontario Pension Plan Trust Fund. Company insiders that have sold Stryker company stock in the last year include Glenn S Boehnlein, Kevin Lobo, M Kathryn Fink, and Timothy J Scannell.
View insider buying and selling activity for Stryker or view top insider-selling stocks.

SYK stock was acquired by a variety of institutional investors in the last quarter, including Ameriprise Financial Inc., Nordea Investment Management AB, Oak Ridge Investments LLC, Canada Pension Plan Investment Board, Barclays PLC, Janus Henderson Group PLC, Morgan Stanley, and Flossbach Von Storch AG.
View insider buying and selling activity for Stryker or or view top insider-buying stocks.

Shares of SYK can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of SYK stock can currently be purchased for approximately $262.64.

Stryker has a market capitalization of $98.95 billion and generates $14.35 billion in revenue each year. The medical technology company earns $1.60 billion in net income (profit) each year or $7.43 on an earnings per share basis.

Stryker employs 43,000 workers across the globe.

The following companies are subsidiares of Stryker: ActiViews, Aimago SA, Alcott Indemnity Company, Arrinex Inc, Arrinex Inc., Ascent Healthcare Solutions, Berchtold, Berchtold + Fritz GmbH, Berchtold Consulting GmbH, Berchtold Corporation, Berchtold GmbH & Co. KG, Berchtold Holding Switzerland GmbH, CHG Hospital Beds, Cactus LLC, Cardan Robotics, Changzhou Orthomed Medical Instrument Company Limited, Concentric Medical, Concentric Medical Inc., Entellus Medical, Entellus Medical Europe Ltd, Entellus Medical Inc., GYS Tech LLC, Gaymar Industries, Gongping (Shanghai) Medical Devices Trading Co. Ltd., Groupe Bertec, HeartSine Technologies LLC, HeartSine Technologies Limited, Howmedica International S. de R.L., Howmedica Osteonics Corp., Hygia Health Services, Hygia Healthcare Services Inc., HyperBranch, HyperBranch Technology Inc., ITAPCo Limited, Image Guided Technologies, Imorphics Limited, Infinity MSD Corp., Infinity MSE Corp., Infinity MSF Corp., Infomedix Communications, Instratek, InstruMedics L.L.C, Invuity Inc., Ivy Sports Medicine, Ivy Sports Medicine LLC, Jiangsu Chuangyi Medical Instrument Company Limited, Jolife AB, K2M Germany GmbH, K2M Group, K2M Group Holdings Inc., K2M Holdings Inc., K2M Iberia Medcomtech S.L.U., K2M Inc., K2M Solutions Australia Pty Ltd, K2M Spine Solutions (Schweiz) GmbH, K2M UK Limited, Loon Intermediateco LLC, MAKO Surgical, MAKO Surgical Corp, Memometal Technologies, Mobius Imaging, Mobius Imaging LLC, Muka Metal, Muka Metal Ticaret ve Sanayi Anaonim Sirketi, NV Stryker SA, Nettrick Limited, Novadaq Corp, Novadaq Hong Kong Ltd, Novadaq Technologies, Novadaq Technologies ULC, OOO "Stryker", Orneo Özel Sağlık Hizmetleri Medikal Ticaret Anonim Şirketi, OrthoSpace, OrthoSpace Ltd., OrthoSpace US Inc., Orthomed (Hong Kong) Medical Instrument Company Limited, Orthovita, Orthovita Inc., OtisMed, P.C. Sweden Holding AB, Patient Safety Technologies, Patton Surgical, Pficonprod Pty. Ltd., Physio-Control, Physio-Control (Shanghai) Sales Co. Ltd., Physio-Control Brazil Vendas Ltda., Physio-Control Czech Sales s.r.o., Physio-Control Holdings Coöperatief U.A., Physio-Control Holdings Inc, Physio-Control Hungary Sales Kft, Physio-Control Inc., Physio-Control India Sales Pvt. Ltd, Physio-Control Investments LLC, Physio-Control Lebanon Sales Offshore s.a.l., Physio-Control Manufacturing Inc., Physio-Control Operations Netherlands B.V., Physio-Control Sales Limited Liability Company, Physio-Control Singapore Pte. Ltd., Physio-Control South Africa Sales Pty. Ltd., Physio-Control UK Sales Ltd., Pivot Medical, PlasmaSol, Porex Technologies, SSI Divestiture Inc., SYK Costa Rica Services Sociedad De Responsabilidad Limitada, SafeAir AG, SafeWire, Sage Products, Sage Products Coӧperatief U.A., Sage Products Holdings II LLC, Sage Products Holdings III LLC, Sage Products LLC, Scopis GmbH, Sightline Technologies, Small Bone Innovations, SpineCore, Spirox Inc., Stanmore Implants Worldwide, Stanmore Implants Worldwide Limited, Stanmore Inc., Stryker (Barbados) Foreign Sales Corporation, Stryker (Beijing) Healthcare Products Co. Ltd., Stryker (Shanghai) Healthcare Products Co. Ltd., Stryker (Suzhou) Medical Technology Co Ltd, Stryker (Thailand) Limited, Stryker AB, Stryker Acquisitions BV, Stryker Asia Holdings CV, Stryker Australia LLC, Stryker Australia Pty. Ltd., Stryker Austria GmbH, Stryker B.V., Stryker Berchtold BV, Stryker Beteiligungs GmbH, Stryker Canada GP ULC, Stryker Canada Holding Company, Stryker Canada Manufacturing ULC, Stryker Canada ULC, Stryker Canadian Management ULC, Stryker Canadian Sales Holding Company ULC, Stryker Capital BV, Stryker China Limited, Stryker Colombia SAS, Stryker Communications Inc., Stryker Corporation (Chile) y Compania Limitada, Stryker Corporation (Malaysia) Sdn. Bhd., Stryker Customs Brokers LLC, Stryker Czech Republic s.r.o., Stryker Delaware Inc., Stryker EMEA Supply Chain Services BV, Stryker Employment Company LLC, Stryker European Coordination Center BV, Stryker European Holdings Coöperatief U.A, Stryker European Holdings I LLC, Stryker European Holdings II LLC, Stryker European Holdings LLC, Stryker European Holdings V LLC, Stryker European Operations B.V., Stryker European Operations Holdings I BV, Stryker European Operations Holdings II BV, Stryker European Operations Holdings III BV, Stryker European Operations Holdings LLC, Stryker European Operations Limited, Stryker European Technologies C.V., Stryker Far East Inc., Stryker Foreign Acquisitions Inc., Stryker France Holding SNC, Stryker France MM Holdings SAS, Stryker France SAS, Stryker Funding B.V., Stryker GI Services CV, Stryker Global Technology Center Private Limited, Stryker GmbH, Stryker GmbH & Co. KG, Stryker Grundstücks GmbH & Co KG, Stryker Grundstücks Verwaltungs GmbH, Stryker Holdings BV, Stryker IFSC Designated Activity Company, Stryker Iberia SL Unipersonal, Stryker India Private Limited, Stryker International Acquisitions BV, Stryker International Holdings BV, Stryker Investment Holdings B.V., Stryker Ireland Holding Unlimited Company, Stryker Ireland Limited, Stryker Italia S.r.l. S.U., Stryker Japan Holdings BV, Stryker Japan K.K., Stryker Korea Ltd., Stryker Lebanon (Offshore) S.A.L., Stryker Leibinger GmbH & Co. KG, Stryker Luxembourg Holdings S.a.r.l., Stryker Luxembourg Sarl, Stryker Manufacturing S. de R.L. de C.V., Stryker Mauritius Holding Ltd., Stryker Medical London LP, Stryker Medtech K.K., Stryker Medtech Limited, Stryker Mexico Holdings B.V., Stryker Mexico SA de CV, Stryker NV Operations Limited, Stryker Nederland BV, Stryker New Zealand Limited, Stryker Osteonics AG, Stryker Pacific Limited, Stryker Performance Solutions LLC, Stryker Polska Sp.z.o.o., Stryker Portugal - Produtos Medicos Unipessoal Lda., Stryker Professional Latin America S. de R.L. de C.V., Stryker Puerto Rico Limited, Stryker Romania SRL, Stryker Sage Inc., Stryker Sales Corporation, Stryker Servicios Administrativos S.de R.L. de C.V., Stryker Singapore Private Limited, Stryker South Africa (Proprietary) Limited, Stryker Spine SAS, Stryker Spine Sarl, Stryker Sustainability Solutions Inc., Stryker Tibbi Cihazlan Sanayi ve Ticaret Limited Sirketi, Stryker Trauma GmbH, Stryker Turkish Holdings BV, Stryker UK Ltd, Stryker Verwaltungs GmbH, Stryker Vietnam Company Limited, Stryker do Brasil Ltda, Surpass Medical, Synergetics, TG SP Holdings Corp, TSO3 Corp, TSO3 Inc, Trauson, Trauson (China) Medical Instrument Company Limited, Trauson (Hong Kong) Company Limited, Trauson Holdings (BVI) Company Limited, Trauson Holdings (Hong Kong) Company Limited, Trauson Holdings Company Limited, VEXIM SA, Vexim, Waterloo Bedding Co., Wright Medical Group, ZipLine Medical Consulting (Shanghai) Co. Ltd., ZipLine Medical Hong Kong Limited, ZipLine Medical Inc., and eTrauma.com.

Stryker was founded in 1941.

The official website for Stryker is www.strykercorp.com.

Stryker is headquartered at 2825 AIRVIEW BLVD, KALAMAZOO MI, 49002.

Stryker's mailing address is 2825 AIRVIEW BLVD, KALAMAZOO MI, 49002. The medical technology company can be reached via phone at (269) 385-2600 or via email at [email protected]